HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis

HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia

(2015) Yoshiteru Takekita et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia

(2015) Dai Wang et al.   Pharmacogenetics and Genomics

COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine

(2015) Marta Bosia et al.   PHARMACOGENOMICS

Transcriptional Dys-regulation in Anxiety and Major Depression: 5-HT1A Gene Promoter Architecture as a Therapeutic Opportunity

(2014) Paul Albert et al.   CURRENT PHARMACEUTICAL DESIGN

Association Between HTR1A Gene Polymorphisms and Attention Deficit Hyperactivity Disorder in Korean Children

(2013) Young Hyun Park et al.   Genetic Testing and Molecular Biomarkers

Investigation of Epistasis Between DAOA and 5HTR1A Variants on Clinical Outcomes in Patients with Schizophrenia

(2013) Alberto Chiesa et al.   Genetic Testing and Molecular Biomarkers

Augmentation of antipsychotic drug action by azapirone 5-HT1A receptor partial agonists: a meta-analysis

(2013) Taro Kishi et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Methylation at a transcription factor-binding site on the 5-HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia

(2013) Hao Tang et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2Aand DA D2antagonism and 5-HT1Apartial agonism

(2013) Mei Huang et al.   JOURNAL OF NEUROCHEMISTRY

Association of 5HTR1A gene variants with suicidal behavior: Case-control study and updated meta-analysis

(2013) Thelma Beatriz González-Castro et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Pharmacogenetics in major depression: A comprehensive meta-analysis

(2013) Tomihisa Niitsu et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Genetic studies indicate a potential target 5-HTR3Bfor Drug Therapy in Schizophrenia Patients

(2012) Meenal Gupta et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder

(2012) Taro Kishi et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment

(2012) Antonio Drago et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The combined effects of the 5- HTTLPR and HTR1A rs6295 polymorphisms modulate decision making in schizophrenia patients

(2012) H. Gu et al.   GENES BRAIN AND BEHAVIOR

Increased Serotonin-1A (5-HT1A) Autoreceptor Expression and Reduced Raphe Serotonin Levels in Deformed Epidermal Autoregulatory Factor-1 (Deaf-1) Gene Knock-out Mice

(2012) Margaret Czesak et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effects of Aripiprazole, Risperidone, and Olanzapine on 5-HT1A Receptors in Patients With Schizophrenia

(2012) Jérôme Lerond et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Transcriptional regulation of the 5-HT1A receptor: implications for mental illness

(2012) P. R. Albert   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Effect of Serotonin-Related Gene Polymorphisms on Pathogenesis and Treatment Response in Korean Schizophrenic Patients

(2011) Yong-Ku Kim et al.   BEHAVIOR GENETICS

The role of serotonin receptors in the action of atypical antipsychotic drugs

(2011) HY Meltzer et al.   CURRENT OPINION IN PHARMACOLOGY

Case–control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics

(2011) Concetta Crisafulli et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties

(2011) Adrian Newman-Tancredi et al.   PSYCHOPHARMACOLOGY

Serotonin-1A receptor gene polymorphism and the ability of antipsychotic drugs to improve attention in schizophrenia

(2010) Tomiki Sumiyoshi et al.   ADVANCES IN THERAPY

Strategies for successful clinical management of schizophrenia with ziprasidone

(2010) Andrea Fagiolini et al.   EXPERT OPINION ON PHARMACOTHERAPY

Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors

(2010) Analía Bortolozzi et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients

(2009) Taro Kishi et al.   NEUROPHARMACOLOGY

The —1019 C/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients

(2008) L. Wang et al.   JOURNAL OF PSYCHOPHARMACOLOGY

HES1 regulates 5-HT1A receptor gene transcription at a functional polymorphism: Essential role in developmental expression

(2008) Kirsten X. Jacobsen et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

(2008) M Kato et al.   MOLECULAR PSYCHIATRY

Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia

(2008) Rainald Mössner et al.   Pharmacogenetics and Genomics

Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia

(2008) Masashi Ikeda et al.   PHARMACOGENOMICS